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1. Introduction
Maintenance of genomic stability is central to cellular homeostasis and self defense from en‐
vironmental or intracellular inducers of DNA damage. Depending on the type of DNA le‐
sion, several DNA repair mechanisms exist. Each major DNA repair process involves the
detection of DNA damage, the accumulation of DNA repair factors at the site of damage
and finally the physical repair of the lesion [1, 2].
The simplest, single enzyme DNA repair pathway is direct reversal or repair (DR) which is
effected by O6-methylguanine-methyltransferase (MGMT), which is an enzyme that directly
reverses DNA alkylation damage at the O6 position of guanine residues [2].
The mismatch repair (MMR) pathway is responsible for repair of ‘insertion and deletion’
loops that form during DNA replication [3]. These errors cause base ‘mismatches’ in the
DNA sequence that distort the helical structure of DNA. Key MMR proteins MSH2 and
MLH1 are involved in detection of this distortion and excision of the mismatch site which is
then followed by new DNA synthesis.
DR is closely associated with MMR as a reduction in MGMT expression resulting from gene
promoter methylation in some tumors, such as gliomas, results in recognition of resultant
DNA mismatches by MMR and ultimate stimulation of pro-apoptotic signals after treatment
with the alkylating agent temozolomide [4].
Repair of DNA alkylation products, oxidative lesions and single strand breaks (SSBs) is
orchestrated by the base excision repair (BER) pathway. BER comprises a first step of re‐
moval of the damaged base from the double DNA helix which is followed by excision of the
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“damaged” area and replacement with newly synthesized DNA [5]. The enzymes poly
(ADP-ribose) polymerase 1 and 2 (PARP1 and PARP2) play a key role in this process, acting
as sensors of DNA damage and signal transducers for subsequent repair. Bulky SSBs, in‐
cluding those caused by ultraviolet radiation are repaired by the nucleotide excision repair
(NER) pathway [6]. NER is divided into two sub-pathways, transcription-coupled repair
(TCR) and global-genome repair (GGR). TCR is involved in repair of lesions that block the
elongating RNA polymerase during transcription, whereas GGR repairs lesions that disrupt
base pairing and distort the DNA helix. The actual mechanism through which NER is effect‐
ed involves surrounding of the lesion, excision by the protein Excision repair cross-comple‐
menting protein 1 (ERCC1) and replacement with the use of the normal DNA replication
machinery [6].
As opposed to SSBs, repair of double strand breaks (DSBs) depends on homologous recom‐
bination (HR) and non-homologous end joining (NHEJ) repair pathways. Homologous re‐
combination involves the resection of DNA sequence around the lesion using the
homologous sister chromatid as a template for new DNA synthesis. Most important HR re‐
pair factors include BRCA1, BRCA2, RAD51 and PALB2 [7]. With regard to NHEJ, DNA re‐
pair involves direct ligation of the ends between DSBs in an error-prone manner. As such,
deletion or mutation of DNA sequences at or around the DSB site may occur [8].
Translesion  synthesis  and  template  switching  are  another  two  DNA  repair  pathways
which  allow DNA to  continue  to  replicate  in  the  presence  of  DNA lesions  that  would
otherwise halt  the process.  In translesion synthesis,  low-fidelity ‘translesion’  DNA poly‐
merases are recruited to the DNA damage site in order to enable DNA synthesis during
DNA replication. When the replication fork passes the DNA damage site, the low-fideli‐
ty  DNA polymerases  are  replaced with the usual  high-fidelity  enzyme to  allow normal
DNA synthesis.  Template switching involves bypass of the DNA damage at the replica‐
tion fork  by leaving a  gap in  DNA synthesis  opposite  the  lesion.  When the  replication
fork passes the DNA damage site, the single-strand gap is repaired using template DNA
on a sister chromatid, as in HR repair [2].
The concept of targeting DNA repair pathways is supported by an increasing amount of evi‐
dence as a potent contributor to the effectiveness of conventional chemotherapy or radio‐
therapy and even as a promising monotherapy in tumors with known DNA repair
deficiencies. Thus, sensitization of cancer cells to DNA damaging agents with DNA repair
inhibitors is an evolving field of cancer research [9]. Further to clinical development of new‐
ly synthesized agents, the exploitation of already existing targeted agents inhibiting growth
signaling pathways would seem a reasonable strategy, given that in most cases of genotoxic
stress, anti-apoptotic and prosurvival signals are activated, rendering the DNA repair ma‐
chinery a vital cellular tool for survival and proliferation.
The  endothelin  (ET)  axis  is  such  a  drugable  target  and  comprises  three  21-amino  acid
peptides,  endothelin-1  (ET-1),  ET-2  and  ET-3,  two  G-protein  coupled  receptor  (GPCR)
subtypes,  endothelin  A (ETRA) and endothelin  B (ETRB) and the endothelin-converting
enzyme (ECE),  which  catalyzes  the  generation  of  active  ET  [10].  The  ET  axis  has  been
previously  implicated  in  the  response  of  endothelial  cells  to  ionizing  radiation  and  it
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could be used as a biomarker for irradiation of endothelial tissues, based on evidence of
transient  increase  of  ET-1  mRNA  accumulation  in  human  vein  endothelial  cells  (HU‐
VECs),  followed by a net increase of ET-1 and big ET-1 peptides in the cytoplasm after
irradiation [11]. In addition, ETRA downregulation was recently identified as part of the
transcriptional  response  of  endothelial  lymphatic  cells  exhibiting  a  chronic  oxidative
stress signature in radiation-induced post-radiotherapy breast angiosarcomas [12]. In gen‐
eral,  the  ET  axis  is  a  key  regulator  of  oncogenic  processes,  as  it  was  shown to  be  ex‐
pressed and active in various cancer and stromal cells leading to autocrine and paracrine
feedback  signaling  loops  promoting  tumor  growth  and  cell  proliferation,  escape  from
apoptosis, angiogenesis, invasion and metastatic dissemination, aberrant osteogenesis and
modification of nociceptive stimuli  [13].  ET-1 is  the most prevalent and well-studied ET
family  member.  ET-1  downstream  signaling  is  mediated  by  ETRA  and  ETRB  whereas
ET-1  clearance  uses  two  pathways:  a)  ETB-mediated  uptake  and  subsequent  lysosomal
degradation [14]  b)  ET-1  cleavage by the  extracellular  membrane enzyme neutral  endo‐
peptidase 24.11 (NEP, neprilysin, CD10) [15].
Aberration of the ET axis, particularly in terms of ET-1 overexpression or/and pertubation of
ETRA to ETRB expression ratio have been consistently associated with malignant transfor‐
mation and progression in colorectal and prostate tissues. ET-1 plasma levels were found to
be increased in patients with colorectal cancer as well as in a rat model of colorectal cancer
in which inhibition of ETAR with a selective antagonist (BQ123) significantly reduced tu‐
mour weight of metastatic lesions to the liver. Further, ETBR gene promoter hypermethyla‐
tion is a frequent event leading to reduced or absent receptor expression [16-18]. Increased
ETAR expression was observed with advancing tumour stage and grade in patients with lo‐
cal and metastatic prostate cancer [19]. In addition, reduced ET-1 clearance due to attenuat‐
ed levels of ETBR and NEP expression further promote increased local ET-1 levels [19, 20].
ET-1 and ETRA are greatly involved in ovarian carcinogenesis and progression and were
both found to be overexpressed in primary and metastatic ovarian tumours [21-23].
With regard to ET-2, emerging data have demonstrated an association between upregula‐
tion of ET-2 transcript levels in human breast cancer cell lines [24] as well as in basal cell
carcinoma as a result of increased Hedgehog signaling [25]. Investigation of the role of ET-3
in cancer has recently revealed a significant reduction in both ET-3 transcript and protein
levels in breast cancer tissues compared with normal tissue, due to hypermethylation of the
ET-3 promoter and subsequent gene silencing [26]. Thus, ET-3 might be considered a signal‐
ing factor with tumor suppressor properties, as opposed to ET-1 and ET-2 [27].
2. DNA damage and the Endothelin Axis
The best example of the involvement of the ET axis in the cellular response after exposure to
DNA damage is the tanning response. After UV irradiation of keratinocytes, upregulation of
a plethora of growth and survival factors occurs, including ET-1, bFGF, NGF, MSH, ACTH,
P-LPH and P-endorphin. The essential roles of the tanning response are prevention of fur‐
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ther DNA damage or/and apoptosis of stressed cells and induction of melanogenesis [28-30].
A better understanding of the signaling events following UV-mediated stimulation of mela‐
nogenesis might enable selective manipulation of these signaling events with the aim of re‐
ducing or/and preventing the damaging effects of UV skin irradiation.
ET-1 has emerged as an excellent inducer of melanogenesis and melanocyte growth, pro‐
moting increased tyrosinase activity after binding to a high-affinity surface receptor [31].
ET-1 was also shown to enhance melanocyte dendricity and to act synergistically with other
factors in UV-irradiated keratinocyte-conditioned medium, whereas this effect was abolish‐
ed by addition of anti - ET-1 antibodies [30]. Thus, ET-1 is the major additional dendricity
factor produced by UV- irradiated keratinocytes, although it is not a major factor in the ab‐
sence of ultraviolet irradiation. Further, incubation of human melanocytes with the same
medium resulted in substantial increase in melanin synthesis which was abrograted by anti
- ET-1 antibodies [30]. Treatment of cultured melanocytes alone with ET-1 rapidly increased
tyrosinase activity and melanogenesis and was responsible for transcriptional upregulation
of tyrosinase and tyrosine-related protein -1 (TRP-1) [32]. Exposure of human epidermis to a
moderate dose of UV radiation led to a significant upregulation of ET-1, interleukin (IL)-1
and tyrosinase gene transcripts. Given that UV irradiation induces IL-1 in keratinocytes, and
IL-1 promotes ET-1 expression in an autocrine manner in the same cells, it is most likely that
subsequent ET-1 release to neighboring melanocytes leads to increased tyrosinase mRNA,
protein and activity, as well as to an increase in melanocyte population. This sequence of
events, in which ET-1 seems to play a key role, has been suggested as a proposed model of
the tanning response in vivo [32, 33].
A key transcriptional factor responsible for skin homeostasis after UV exposure is retinoid X re‐
ceptor a (RXRa). Retinoids have been shown to regulate skin development, differentiation, and
homeostasis, which are mediated by nuclear receptors such as retinoid acid receptors and reti‐
noid X receptors (RXRs) [34, 35]. RXRa is the most abundant RXR isoform in skin and is impli‐
cated in  the  regulation  of  oxidative  DNA damage and skin  apoptosis  and proliferation
mechanisms of epidermal and dermal melanocytes following UV irradiation. This is mostly ef‐
fected through regulation of secreted paracrine factors involved in the crosstalk between kera‐
tinocytes and melanocytes. Increased secretion of mitogenic paracrine factors, including ET-1,
from mutated keratinocytes lacking RXR led to a significant increase in melanocytes after cul‐
ture with conditioned keratinocyte medium following UV irradiation. Given that ET-1 was
previously shown to regulate melanocyte proliferation and melanogenesis [36, 37] and that p53
upregulates ET-1 in UV irradiated keratinocytes [38, 39], it was suggested that p53 might be the
link between RXRa and ET-1. However no recruitment of RXRa was found on the p53 promot‐
er [40]. It is therefore possible that RXRa may directly or indirectly modulate expression of ET-1
and other paracrine survival factors to regulate melanocyte homeostasis [41].
ETRB was found to be expressed in human glioma cells [42, 43]. Based on this finding, treat‐
ment with ETRB inhibitors led to induction of cell cycle arrest and apoptosis. This was at
least partially explained by DNA damage-mediated induction of genes encoding Growth
Arrest and DNA Damage-inducible (GADD)153, GADD45A, GADD34, sestrin 2 and death
receptor 5 (DR5). Up-regulation of the same genes was also observed in human melanoma
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cell lines under the same conditions [44]. This evidence suggests that ETRB inhibition causes
induction of DNA damage response mediators.
The central role of ET axis signaling in glioblastoma (GBM) was further evidenced by the emer‐
gence of ET-3 overexpression in GBM stem cells (GSC). Serum-induced proliferation and sub‐
sequent differentiation was associated with reduced ET-3 secretion and down-regulation of
genes related with stemness, while upregulation of ET-1 and YKL-40 gene products. This was
also evidenced in tissues from patients with GBM which were found to have low ET3 but high
ET-1 and YKL-40 transcript levels. When the ET3/ETRB cascade was blocked either with the
use of an ETRB antagonist or ET-3 RNA interference (siRNA), a plethora of genes were found to
be downregulated, most of which were involved in cytoskeleton organization, pause of growth
and differentiation, and DNA repair. With regard to the latter, most important DNA damage
control and repair genes involved were found to be NIPBL (Nipped-B homolog),  DHX9
[DEAH (Asp-Glu-Ala-His) box polypeptide 9], GTSE1 (G-2 and S-phase expressed 1), and RIF1
(RAP1 interacting factor homolog). These data support the existence of an intimate relation be‐
tween ET-3/ETB signaling and maintenance of GSC phenotype in terms of migration, undiffer‐
entiation, and survival [45]. A simplified schema of the role of ET axis in DNA damage control
and repair in GBM cells is depicted in Figure 1.
Figure 1. Simplified schema of the DNA damage control and repair transcriptional regulation by the ET axis in GBM cells.
An intriguing part of the association between ETRB and response to DNA damage in both
glioma and melanoma cells is that cellular death was not found to be dependent on ETRB
signaling. First, treatment with ETRB antagonists was able to reduce cell viability at higher
doses compared to the ones required to inhibit the ET-1−ETRB ligation. Second, ETRB antag‐
onism in glioma cells with undetectable ETRB was able to induce cell death. Third, experi‐
mental reduction of ETRB expression in other cell lines by >90% had no effect on cell
viability of glioma or melanoma cells [44]. It might be hypothesized that melanoma and
glioma cells follow a distinct pattern of response to treatment with ETRB antagonists that
should be further elucidated.
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3. DNA repair and the Endothelin axis
A significant amount of data supports a pro-survival effect of ET-1 after UV irradiation on
human melanocytes. The anti-apoptotic role of ET-1 was shown to be a receptor-mediated
effect, unrelated to ET-1-mediated mitogenic or melanogenic events, as it was replicated on
melanocytes with no significant increase of cell proliferation as well as in melanocytes that
lacked the ability to synthesize melanin. ET-1 treatment rescued melanocytes from UV-in‐
duced apoptosis as evidenced by reduced Annexin V staining and increased Bcl-2 levels. In
addition, ET-1 promoted cell survival after UV irradiation through activation of the PI3K
pathway. Inhibition of PI3K/Akt signaling attenuated the anti-apoptotic effect of ET-1 on ir‐
radiated melanocytes [46]. ET-1 was also demonstrated to be responsible for phosphoryla‐
tion of Mitf, a helix-loop-helix transcription factor that is central to melanogenesis and
survival of melanocytes [46]. Mitf phosphorylation is effected through ET-1-dependent acti‐
vation of the mitogen-activated protein (MAP) kinases ERK1/2, which in turn phosphorylate
the transcription factor CREB, upstream of Mitf [47, 48].
More importantly, when human epidermal keratinocytes were exposed to 6-hour UVB irra‐
diation, a dual transcriptional response was observed involving upregulation of several
apoptosis-related and DNA repair factors. TRAF-interacting protein (hTRIP), CD40 recep‐
tor- associated factor-1 (CRAF), cytotoxic ligand TRAIL receptor, death-associated protein
kinase 1 (DAPK1) [49-51], but also ERCC1 (NER) and XRCC1 (BER) [52–54] were all found
to be upregulated. These changes were in parallel with reduced expression of ET-2 at 6 h
post-irradiation. Therefore, it might be that the final cellular fate after exposure to genotoxic
stress by UV irradiation is determined by a balance between DNA repair and apoptotic
processes, in both of which ET signaling seems to play a role [55].
Another important observation regarding the association between the ET axis and DNA re‐
pair is that ET-1 reduces UV-induced DNA photoproducts, thus implying an involvement of
ET-1 in enhancement of NER. Therefore, ET-1 signaling not only exerts a proliferative and
anti-apoptotic effect but also reduces accumulation of DNA damage, which is indispensable
for maintenance of genomic health. The implication of pro-survival signals, other than the
ET family, in DNA repair of keratinocytes has also been described for interleukin-12 (IL-12)
and IGF-I which were both found to accelerate the removal of DNA photoproducts thus pre‐
venting UV-induced apoptosis in these cells [56, 57].
In addition to the direct DNA damaging effects of exposure to UV radiation, the latter is also
a major source of reactive oxygen species (ROS) production that can secondarily cause oxi‐
dative DNA damage, as well as lipid peroxidation and protein damage [58]. Increased pro‐
duction of hydrogen peroxide, which is the main representative of ROS, following UV
exposure was found to be reversed by ET-1 in human melanocytes. Thus, ET-1-mediated
prevention of UV-induced oxidative stress indirectly contributes to prevention of oxidative
DNA damage. Overall, activation of melanocortins and ET-1 signaling constitutes an indis‐
pensable cellular mechanism to overcome cancer-promoting effects of UV irradiation
through reduced generation of hydrogen peroxide-mediated DNA damage and activation of
DNA repair and melanogenesis pathways [46].
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Accumulated evidence supports that melanoma patients have lower DNA repair capacity
compared to the general population. Risk of melanoma was found to be increased by loss-of-
function mutations in the melanocortin-1 receptor gene, indicating that inefficient or/and aber‐
rant  DNA  repair  is  central  to  the  development  of  melanoma.  UV  irradiation  induces
upregulation of various pro-survival signaling molecules including NGF, NT-3, MSH and
ACTH, and ET-1. This upregulation seems to have a double effect on skin melanocytes. An ear‐
ly response involves inhibition of apoptotic signaling elicited by UV-induced DNA damage in
melanocytes as well as enhancement of DNA photoproducts and oxidative stress metabolites,
particularly hydrogen peroxide. According to the proposed model, exposure of the skin to UV
radiation stimulates the activation of a MSH-, ACTH-, and ET-1-dependent paracrine network
that promotes melanocyte survival, enhances the repair of cyclobutane pyrimidine dimmers
(CPD) and reduces the release of hydrogen peroxide. Collectively, these effects represent the
immediate response to UV irradiation, which is followed by a delayed response of increased
melanogenesis to establish photoprotection. Thus, melanocortins and ET-1 operate to maintain
genomic stability of melanocytes and prevent evolution of unrepaired DNA damage to skin
carcinogenesis [59].
There appears to be a direct association between ETRB signaling and expression of the BER
member protein PARP-3. PARP-3 is part of a family of DNA damage surveillance factors
[60]. ETRB antagonism was found to induce down-regulation of PARP-3 transcription in
melanoma cell lines derived from primary tumors and metastases (cutaneous, lymph node,
visceral) with the most prominent effect observed on the lines that were more sensitive to
ETRB inhibition. Further, the extent of PARP-3 downregulation correlated with the level of
apoptosis evidenced by histone-associated DNA fragmentation. The strongest decrease in
PARP-3 expression in response to ETRB antagonism occurred in distal metastasis-derived
cells, with little or no changes observed in primary tumor-derived melanoma cells [61].
A simplified schema of the role of ET axis in DNA damage response and repair in melano‐
ma cells is depicted in Figure 2.
Figure 2. Simplified schema of the DNA damage control and repair transcriptional regulation by the ET axis in mela‐
noma cells.
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4. Conclusions
It is evident that the ET axis is greatly involved in the modulation of DNA repair processes.
Elucidation of regulatory loops between ET family members and DNA repair factors at the
transcriptional or/and post-translational level is a field of ongoing research. As expected, the
use of existing or/and development of new targeted agents interfering with inhibition of ET
signaling might be exploited either alone or in combination with chemotherapeutic drugs
based on emerging mechanisms of action of the latter associated with DNA repair inhibition
and sensitization of tumors to DNA damage.
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